Valeant Pharmaceuticals International Inc. has made mistakes and been too aggressive in the past in dramatically boosting the price of some of its drugs, the company’s outgoing chief executive is expected to tell a Senate committee Wednesday.
from WSJ.com: US Business http://ift.tt/1Wp0BZz
via IFTTT
No comments:
Post a Comment